Patients suffering from Hypermobility Spectrum Disorder (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS) face an average diagnostic delay of 19 to 21.7 years in the United Kingdom, according to a study from the University of Edinburgh. The condition, which affects connective tissue and causes joints to exceed normal ranges of motion, leaves hundreds of thousands of people dealing with severe fatigue, chronic pain, and digestive issues without a clear medical answer.
The findings highlight a widespread systemic gap in recognizing connective tissue disorders. Unlike more visible musculoskeletal conditions, hypermobility disorders lack a specific, independent clinical guidance pathway from the National Institute for Health and Care Excellence (NICE). This regulatory absence creates what researchers describe as a diagnostic lottery, where a patient’s access to timely evaluation depends entirely on their geographic location.
How Hypermobility Spectrum Disorder Affects the Body
The physical toll of HSD stems from a fundamental lack of collagen between connective tissues. Because the body’s structural framework is overly elastic, muscles must work overtime to maintain skeletal stability. This constant strain leads directly to exhaustion, clumsiness, and widespread joint pain.
Internal organs are affected as well. The digestive system relies on connective tissue to function efficiently; when that tissue is too flexible, patients frequently experience gastrointestinal complications. In its most severe presentation—hypermobile Ehlers-Danlos syndrome—defective connective tissue spans the entire body, triggering frequent joint dislocations.
Medical Experts Call for Intergovernmental and Specialist Action
Data from the University of Edinburgh investigation reveals that fewer than one-third of diagnosed patients report that their general practitioner initiated treatment, and only 13% ever gain access to a specialist physician. Dr. Jessica Eccles, an expert in brain-body interactions and hypermobility, notes that these conditions disproportionately affect women. Dr. Eccles points out that female health concerns historically receive less research focus than male-centric medical conditions. Dr. Barrett argues that simply telling patients to perform light physiotherapy and return to their daily lives is inadequate. Managing the condition requires coordinated multidisciplinary care, governmental recognition, and specialized resources to prevent patients from falling through the cracks of the healthcare system.